Question · Q4 2025
Seth Weber, Equity Research Analyst at BNP Paribas, inquired about the Healthcare cross-selling opportunity, asking if the focus remains on small and medium-sized customers or if WM is gaining better traction with large hospital networks. He also requested an update on the national accounts business across the entire company, specifically if its low double-digit CAGR is continuing or improving in 2025.
Answer
CEO Jim Fish stated that the Healthcare cross-selling opportunity is ultimately expected to be more significant with large hospital networks, as decision-makers for solid waste and healthcare waste are often the same, and WM's combined service offerings resonate strongly. Jim Fish also highlighted that the national accounts business has been a "real success story" for WM, demonstrating strong performance in both volume and price through differentiated service and data analytics, improving significantly over the past decade.
Ask follow-up questions
Fintool can predict
WM's earnings beat/miss a week before the call